MEREDITH HAEDTLER: Open Payments
NPI 1245862010 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,716 in 91 payments from 20 companies in 2025. Trend: 2023 $1,270 · 2024 $2,154 · 2025 $1,716
Food & beverage: $1,716
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 16 | $349 |
| Novartis Pharmaceuticals Corporation | 20 | $310 |
| Merck Sharp & Dohme LLC | 14 | $257 |
| Astellas Pharma US Inc | 9 | $164 |
| PFIZER INC. | 7 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Lilly USA, LLC | 3 | $47 |
| TerSera Therapeutics LLC | 2 | $44 |
| Geron Corporation | 1 | $38 |
Products named: DATROWAY, KEYTRUDA, KISQALI, Fabhalta, Vyloy, Enhertu, IBRANCE, FRUZAQLA.
Industry payments across KY — which companies pay providers there.
